Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Quadrivalent Influenza Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01964989
What this trial is testing

Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.

Who this might be right for
Influenza Virus
Seqirus 10,644
Testing effectiveness (Phase 2)Study completedNCT05553301
What this trial is testing

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 560
Large-scale testing (Phase 3)Study completedNCT06279871
What this trial is testing

Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults

Who this might be right for
COVID-19
Arcturus Therapeutics, Inc. 1,514
Post-approval studies (Phase 4)Study completedNCT03600428
What this trial is testing

Safety of LAIV4 in Children With Asthma

Who this might be right for
Asthma in ChildrenVaccine Adverse ReactionVaccine Reaction+3 more
Vanderbilt University Medical Center 152
Large-scale testing (Phase 3)WithdrawnNCT04848467
What this trial is testing

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

Who this might be right for
SARS-CoV-2 InfectionCoronavirus Disease 2019 (COVID-19)
Bayer
Large-scale testing (Phase 3)Study completedNCT04498832
What this trial is testing

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults 60 Years of Age and Older

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 2,100
Early research (Phase 1)Study completedNCT03453801
What this trial is testing

The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection

Who this might be right for
InfluenzaHealthy
Stanford University 80
Not applicableStudy completedNCT06334510
What this trial is testing

Evaluate the Safety and Efficacy of Quadrivalent Influenza in Real-world Situations.

Who this might be right for
GCP
Hualan Biological Bacterin Co. Ltd. 4,900
Not applicableWithdrawnNCT02000466
What this trial is testing

FluLaval® Quadrivalent Pregnancy Registry

Who this might be right for
Influenza
GlaxoSmithKline
Large-scale testing (Phase 3)WithdrawnNCT01810731
What this trial is testing

Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya

Who this might be right for
Influenza, HumanHIVMalaria+2 more
Centers for Disease Control and Prevention
Large-scale testing (Phase 3)Study completedNCT05869201
What this trial is testing

Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine

Who this might be right for
InfluenzaInfluenza, HumanInfluenza Viral Infections+2 more
St. Petersburg Research Institute of Vaccines and Sera 450
Post-approval studies (Phase 4)UnknownNCT02563184
What this trial is testing

Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
Banner Health 100
Testing effectiveness (Phase 2)Study completedNCT02768805
What this trial is testing

Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults

Who this might be right for
Virus DiseasesRNA Virus InfectionsRespiratory Tract Diseases+1 more
Medicago 900
Early research (Phase 1)Study completedNCT04144179
What this trial is testing

Safety and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Formulations Containing Different H3 Hemagglutinin Antigens in Healthy Adult Subjects 18 to 30 Years of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 150
Large-scale testing (Phase 3)Study completedNCT02255409
What this trial is testing

Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine (QIV) in Children Previously Vaccinated in Trial V118_05

Who this might be right for
Influenza
Seqirus 607
Large-scale testing (Phase 3)Study completedNCT01218308
What this trial is testing

Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children

Who this might be right for
Influenza
GlaxoSmithKline 5,220
Large-scale testing (Phase 3)Study completedNCT03718468
What this trial is testing

Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine

Who this might be right for
Influenza
Medigen Vaccine Biologics Corp. 842
Large-scale testing (Phase 3)Study completedNCT05568797
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,045
Large-scale testing (Phase 3)Study completedNCT02242643
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age

Who this might be right for
Influenza
GlaxoSmithKline 2,432
Not applicableStudy completedNCT07332689
What this trial is testing

Safety Study of Quadrivalent Subunit Influenza Vaccine in People Aged 3 Years and Older

Who this might be right for
Influenza Vaccine
Ab&B Bio-tech Co., Ltd.JS 42,881
Next Page